Myofibroblastic srcoma vs nodular fasciitis a comparative Study of chromosomal imbalances

American Journal of Clinical Pathology

Volumn 131, Issue 5, 2009, Pages 701-709

  Meng, Guo Zha ^a   Zhang, Hong Ying ^a,b   Zhang, Zhang ^a   Wei, Bing ^a   Bu, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

CGH; Comparative genomic hybridization; Myofibroblastic sarcoma; Nodular fasciitis

Indexed keywords

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CHROMOSOME; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CYTOGENETICS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DNA ISOLATION; FASCIITIS; FEMALE; GENOME; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MALE; MEDICAL RECORD; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MOLECULAR HYBRIDIZATION; MOLECULAR IMAGING; MYOFIBROBLASTIC SARCOMA; NODULAR FASCIITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SARCOMA; WORLD HEALTH ORGANIZATION; ADOLESCENT; ANEUPLOIDY; GENE DOSAGE; GENETICS; KARYOTYPING; METASTASIS; MIDDLE AGED; MYOSARCOMA; PATHOLOGY; SOFT TISSUE TUMOR; TUMOR RECURRENCE;

DNA;

ADOLESCENT; ADULT; AGED; ANEUPLOIDY; COMPARATIVE GENOMIC HYBRIDIZATION; DNA, NEOPLASM; FASCIITIS; FEMALE; GENE DOSAGE; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; MYOSARCOMA; NEOPLASM RECURRENCE, LOCAL; SOFT TISSUE NEOPLASMS; YOUNG ADULT;

EID: 65349166624     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPV6H2WSYXLKFB     Document Type: Article

References (39)

1. Montgomery E, Goldblum JR, Fisher C. Myofibrosarcoma: a clinicopathologic study. Am J Surg Pathol. 2001;25:219-228.
2. Smith DM, Mahmoud HH, Jenkins JJ III, et al. Myofibrosarcoma of the head and neck in children. Pediatr Pathol Lab Med. 1995;15:403-418.
3. Taccagni G, Rovere E, Masullo M, et al. Myofibrosarcoma of the breast: review of the literature on myofibroblastic tumors and criteria for defining myofibroblastic differentiation. Am J Surg Pathol. 1997;21:489-496.
4. Mentzel T, Dry S, Katenkamp D, et al. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol. 1998;22:1228-1238.
5. Meng GZ, Zhang HY, Bu H, et al. Myofibroblastic sarcomas: a clinicopathological study of 20 cases. Chin Med J (Engl). 2007;120:363-369.
6. Meng GZ, Zhang HY, Bu H, et al. Myofibroblastic sarcoma of the nasal cavity and paranasal sinus: a clinicopathologic study of 6 cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:530-539.
7. Mentzel T, Fletcher JA. Low grade myofibroblastic sarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:94-95. World Health Organization Classification of Tumours.
8. Bisceglia M, Tricarico N, Minenna P, et al. Myofibrosarcoma of the upper jawbones: a clinicopathologic and ultrastructural study of two cases. Ultrastruct Pathol. 2001;25:385-397.
9. Schurch W, Seemayer TA, Gabbiani G. The myofibroblast: a quarter century after its discovery. Am J Surg Pathol. 1998;22:141-147.
10. du Manoir S, Speicher MR, Joos S, et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet. 1993;90:590-610.
11. Morawietz L, Kuhnen C, Katenkamp D, et al. Unusual sarcomatoid neoplasm of the lung suggesting a myofibrosarcoma. Virchows Arch. 2005;447:990-995.
12. Fletcher CDM, Dal Cin P, de Wever I, et al. Correlation between clinicopathological features and karyotype in spindle cell sarcomas: a report of 130 cases from the CHAMP study group. Am J Pathol. 1999;154:1841-1847.
13. Birdsall SH, Shipley JM, Summersgill BM, et al. Cytogenetic findings in a case of nodular fasciitis of the breast. Cancer Genet Cytogenet. 1995;81:166-168.
14. Velagaleti GV, Tapper JK, Panova NE, et al. Cytogenetic findings in a case of nodular fasciitis of subclavicular region. Cancer Genet Cytogenet. 2003;141:160-163.
15. Weibolt VM, Buresh CJ, Roberts CA, et al. Involvement of 3q21 in nodular fasciitis. Cancer Genet Cytogenet. 1998;106:177-179.
16. Donner LR, Silva T, Dobin SM. Clonal rearrangement of 15p11.2, 16p11.2, and 16p13.3 in a case of nodular fasciitis: additional evidence favoring nodular fasciitis as a benign neoplasm and not a reactive tumefaction. Cancer Genet Cytogenet. 2002;139:138-140.
17. Noguchi T, Wirtz HC, Michaelis S, et al. Chromosomal imbalances in gastric cancer: correlation with histologic subtypes and tumor progression. Am J Clin Pathol. 2001;115:828-834.
18. Larramendy ML, Tarkkanen M, Blomqvist C, et al. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol. 1997;151:1153-1161.
19. Rickert CH, Wiestler OD, Paulus W. Chromosomal imbalances in choroid plexus tumors. Am J Pathol. 2002;160:1105-1113.
20. Jones C, Damiani S, Wells D, et al. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol. 2001;158:207-214.
21. Derre J, Lagace R, Nicolas A, et al. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest. 2001;81:211-215.
22. Sxymanska J, Tarkkanen M, Wiklund T, et al. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer. 1996;15:89-94.
23. Weber-Hall S, McManus A, Anderson J, et al. Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma. Genes Chromosomes Cancer. 1996;17:7-13.
24. Nau MM, Brooks BJ, Battey J, et al. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature. 1985;318:69-73.
25. Brzoska PM, Levin NA, Fu KK, et al. Frequent novel DNA copy number increase in squamous cell head and neck tumors. Cancer Res. 1995;55:3055-3059.
26. Roelofs H, Mostert MC, Pompe K, et al. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am J Pathol. 2000;157:1155-1166.
27. Pulciani S, Santos E, Long LK, et al. Ras gene amplification and malignant transformation. Mol Cell Biol. 1985;5:2836-2841.
28. Mostert MC, Verkerk AJ, van de Pol M, et al. Identification of the crucial region of 12p over-representation in testicular germ cell tumors of adolescents and adults. Oncogene. 1998;16:2617-2627.
29. Courjal F, Louason G, Speiser P, et al. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer. 1996;69:247-253.
30. El-Rifai W, Sarlomo-Rikala M, Knuutila S, et al. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am J Pathol. 1998;153:985-990.
31. Zhang H, Kobayashi R, Galaktionov K, et al. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S-phase kinase. Cell. 1995;82:915-925.
32. Linn SC, West RB, Pollack JR, et al. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Am J Pathol. 2003;163:2383-2395.
33. Richter H, Slezak P, Walch A, et al. Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms. Am J Pathol. 2003;163:287-294.
34. Li LS, Kim NG, Kim SH, et al. Chromosomal imbalances in the colorectal carcinomas with microsatellite instability. Am J Pathol. 2003;163:1429-1436.
35. Gommans IM, Davis M, Saar K, et al. A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core like lesions. Brain. 2003;126(pt 7):1545-1551.
36. Montgomery E, Fisher C. Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study. Histopathology. 2001;38:499-509.
37. Mairal A, Terrier P, Chibon F, et al. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas: a comparative genomic hybridization analysis of a series of 30 cases. Cancer Genet Cytogenet. 1999;111:134-138.
38. INK4A) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet. 2000;118:89-98.
39. Weng WH, Ahlen J, Lui WO, et al. Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis. Br J Cancer. 2003;89:720-726.